is the labeled adult aripiprazole dose for schizophrenia 10-15 mg a day, with a 30 mg maximum
“The labeled adult dose for schizophrenia is 10-15 mg a day. The maximum is 30 mg a day.”
a host said on Psychopharmacology and Psychiatry Updates, 2026-10-09, at 13:52. hear it in context → the speaker cited: the label.
the episode: Schizophrenia: Which of Seven Antipsychotics Wins? (at 13:52). we link the show's own page; we do not re-host audio.
first, the part that holds
the host has it right. the current FDA-approved labeling for oral aripiprazole lists 10 to 15 mg/day as both the starting and recommended dose for adults with schizophrenia, and 30 mg/day as the maximum.
what we found when we went and looked
we read two current DailyMed labels for oral aripiprazole: the reference listed drug's labeling (revised 1/2025) and a generic tablet label (revised 3/2025). both dosage tables give the adult schizophrenia row as initial dose 10 to 15 mg/day, recommended dose 10 to 15 mg/day, maximum dose 30 mg/day. section 2.1 adds that the drug was shown to work across 10 to 30 mg/day, but "doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day." the label also tells prescribers to give half the usual dose to known CYP2D6 poor metabolizers and to people taking strong CYP2D6 or CYP3A4 inhibitors, and a quarter of it when both apply. so for some adults the labeled dose sits below 10 mg.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| the FDA-labeled adult dose of aripiprazole for schizophrenia is 10-15 mg per day | confirmed | the dosage table in both labels reads 'schizophrenia – adults: initial dose 10 to 15 mg/day, recommended dose 10 to 15 mg/day.' the section 2.1 text words it as '10 or 15 mg/day' as the starting and target dose. this covers oral tablets only. long-acting injectables are dosed on separate labels [1][2] |
| the labeled maximum for adults with schizophrenia is 30 mg per day | confirmed | the maximum dose column for adults with schizophrenia reads '30 mg/day' in both the reference label (rev. 1/2025) and the generic label (rev. 3/2025) [1][2] |
| the label says doses above 10-15 mg/day add effectiveness for schizophrenia | false | this is a popular reading of 'maximum', not something the host said. section 2.1 says the drug was shown to work across 10 to 30 mg/day but 'doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day.' that comes from the registration trials and is group-level. it does not tell you how any one person will respond [1][2] |
| 10-15 mg/day is the labeled dose for every adult with schizophrenia | overstated | this is context, not the host's claim. the label tells prescribers to give half the usual dose to known CYP2D6 poor metabolizers and to people taking strong CYP2D6 or CYP3A4 inhibitors, and a quarter of it when both apply. for those adults the labeled dose falls below 10 mg/day [2] |
both directions
for the speaker: both labels we read have the same adult schizophrenia row: 10 to 15 mg/day to start, 10 to 15 mg/day recommended, 30 mg/day maximum. the 2025 generic label matches the reference label, so the numbers are current and not left over from an older version.
against: nothing in the label contradicts the two numbers. the context the quote leaves out runs the other way: the label says doses above 10 or 15 mg/day were no more effective in the trials, so 30 mg is a ceiling, not a step up in benefit. it also halves or quarters the dose for CYP2D6 poor metabolizers and for people on certain interacting drugs. the adolescent row (2 mg/day start, 10 mg/day recommended, 30 mg/day maximum) is different, and the host correctly limited the claim to adults.
what this cannot say
a label records what the FDA approved and the evidence behind that approval. it does not record what prescribers do in practice or how well a given dose works for one person. we checked oral tablet labels only. long-acting injectable aripiprazole products have their own dosing and were not part of this check. we read two of the many generic labels on DailyMed, not all of them.
sources, each one fetched and read
- DailyMed, National Library of Medicine. aripiprazole tablets, reference listed drug prescribing information. revised 1/2025. setid c040bd1d-45b7-49f2-93ea-aed7220b30ac What we read there: 'the recommended starting and target dose ... is 10 or 15 mg/day' ... 'effective in a dose range of 10 to 30 mg/day' ... 'doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day'. table: schizophrenia – adults, initial 10 to 15 mg/day, recommended 10 to 15 mg/day, maximum 30 mg/day Fetched 2026-10-15 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac
- DailyMed, National Library of Medicine. aripiprazole tablets, generic prescribing information. revised 3/2025. setid 85cc7d25-414b-4b6f-a03a-48af908a16a1 What we read there: adult schizophrenia: initial 10 to 15 mg/day, recommended 10 to 15 mg/day, maximum 30 mg/day. adolescents: initial 2 mg/day, recommended 10 mg/day, maximum 30 mg/day. known CYP2D6 poor metabolizers or strong CYP2D6/CYP3A4 inhibitors: 'administer half of usual dose'. both: 'administer a quarter of usual dose' Fetched 2026-10-15 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85cc7d25-414b-4b6f-a03a-48af908a16a1
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam